An entirely subcutaneous implantable cardioverter-defibrillator.

By G. Bardy, Warren M. Smith, M. Hood, I. Crozier, I. Melton, L. Jordaens, D. Theuns, R. E. Park, D. Wright, D. Connelly and 17 more. New England Journal of Medicine, 2010

691 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Neurology

View Paper: https://www.semanticscholar.org/paper/72f2d1d973d6e28cc7d8e133b9f09cd63ca97603

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. F. Kusumoto
2. M. Schoenfeld
3. M. Jessup
4. P. Ponikowski
5. C. Berul
6. A. Voors
7. K. Ellenbogen
8. U. Birgersdotter-Green

Citations in the corpus

• 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2016, positive): “238 Subcutaneous defibrillators may be as effective as conventional ICDs with a lower risk from the implantation procedure.(256,257)”
• 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. (2017, background): “Subcutaneous Implantable Cardioverter Defibrillators An entirely subcutaneous ICD (S-ICD) has been recently introduced, which prevents the inherent problems related to transvenous leads.(30) The S-ICD consists of a pulse generator implanted in a left mid-axillary position connected to an entirely su”
• 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the preventionof sudden cardiac death (2015, neutral): “The device is capable of defibrillating most patients with an output of 80 J.(159) The available data suggest that subcutaneous defibrillators are effective in preventing sudden death.”